The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres
29/04/2026
Congratulations to CCC Financial Accountant Lorraine Flynn who has won a top national award for her inspirational career journey and achievements 👏
Lorraine was the winner of the Distance Learning Student of the Year Award at this year's PQ accountancy awards, which took place in London on Monday 27 April 2026.
Lorraine said: “I’m absolutely thrilled to receive this award. Being named Distance Learning Student of the Year is an incredible honour, especially as I have now fully qualified. I’m very grateful to my colleagues and mentors for their support, and I’m excited to keep learning, growing, and developing in the profession.”
Please remember, if you are a patient currently being treated by The Clatterbridge Cancer Centre or you completed treatment with us in the last six weeks, and you need urgent advice or care related to your cancer treatment or diagnosis, our Hotline team is available to help 24 hours a day, seven days a week.
Call 0800 169 5555 to speak to one of our expert nurses.
28/04/2026
If you’re 50 to 74, the NHS will send you a testing kit.
Even if you don't have symptoms, it can detect signs of bowel cancer before you do, and catching it early reduces your chances of getting seriously ill.
So, don’t just leave it in the back of a drawer - send it back today. Find out more 👉 https://orlo.uk/kS0Bm
24/04/2026
If you're looking for a career change or challenge, we've got some fantastic roles available!
Vacancies include - Chemotherapy Staff Nurse, Macmillan Welfare Benefits Advisor, and Patient Services Officer.
Rachael Hines has metastatic HER2+ breast cancer. She is taking part in a research study at The Clatterbridge Cancer Centre in Liverpool on the feasibility of offering routine brain MRI scans to people like her. HER2+ breast cancer is more likely to spread to the brain than other breast cancers.
The research is sponsored by The Clatterbridge Cancer Centre and funded by Make 2nds Count. The Co-Chief Investigators are Prof Carlo Palmieri of The Clatterbridge Cancer Centre and University of Liverpool and Dr Sara Meade of University Hospitals Birmingham.
22/04/2026
Do you want to help with cancer research?
A new study is looking for people to give their views of x-rays and scans so that services can be improved for future patients.
If you can take part, please see the image for further details and how to contact the research team.
21/04/2026
Congratulations to Financial Accountant Lorraine Flynn who has been shortlisted for a national award for her inspirational career journey and achievements.
Lorraine, who initially studied orthoptics before leaving university to care for her children, has overcome incredible odds in recent years to become a fully qualified accountant despite experiencing a stroke in 2020 and a series of other obstacles.
After joining an accountancy firm as a receptionist in 2018, Lorraine became interested in it as a career. She began studying part-time for the internationally recognised ACCA qualification in accountancy, and also for a degree in applied accounting. Initially her studies went well and Lorraine progressed through the first few modules without too many problems, balancing her academic work with her job and a busy family life.
But in 2020 everything changed. First, the COVID pandemic meant all the exam centres shut down. Then, in June 2020, Lorraine experienced a stroke that significantly affected her memory and concentration, as well as some physical effects.
"It was very frustrating," says Lorraine. "I was used to being able to pick things up quite easily but I started failing exams and finding it much harder to concentrate, understand and remember things. Worst of all, I lost all my ability with numbers which was obviously a problem studying accountancy.
“I am quite stubborn, though, so I persevered and learnt different strategies to help me remember all the concepts.”
Lorraine joined The Clatterbridge Cancer Centre's finance team in July 2021, initially working in accounts receivable processing invoices and incoming payments. Despite all the challenges, she stuck with her studies over the next few years and was encouraged by her colleagues in our Finance Team.
And in 2025, she achieved the triple successes of completing her ACCA qualification to become a fully qualified accountant, graduating with a degree in applied accounting, and being promoted to a role as a Financial Accountant at The Clatterbridge Cancer Centre.
Now she is one of three finalists in the national PQ accountancy award for 'Distance Learner of the Year' after being nominated by Acowtancy, her learning provider. Lorraine will find out if she has won on Monday 27 April 2026.
Lorraine said: "I am incredibly proud of what I have achieved. I have teenage sons and I hope it shows them that if you knuckle down, do the work and keep going even when it's hard, you can achieve amazing things."
Lucy Blackhurst, Deputy Director of Finance at The Clatterbridge Cancer Centre, said: "Lorraine really is an inspiration. She has always been a hugely valued member of the team and we are so delighted at all she has achieved. She really deserves an award so we all have our fingers crossed for her."
17/04/2026
If this week has convinced you it's time for a more fulfilling job, come and work for us! We've got some great opportunities available, including:
Pharmacy Procurement Assistant, Patient Services Clerk, and Deputy Ward Manager.
The Lord Mayor of Liverpool, Councillor Barbara Murray, made a special visit to Clatterbridge Cancer Centre - Liverpool (CCC-Liverpool) on Monday to learn all about the specialist cancer care we provide and to meet patients and staff.
The Lord Mayor's visit included a tour of our Teenage and Young Adult (TYA) unit, which supports young people with cancer aged 16 to 24 from across Cheshire and Merseyside, the Isle of Man, parts of Lancashire and North Wales. She visited our radiotherapy unit and saw one of our advanced linear accelerators that uses highly-targeted radiation beams to treat cancer.
The Lord Mayor also visited our early trials unit where she found out about the pioneering research we are doing on cancer vaccines and our Phase I clinical trials - also known as 'first in human' trials as they involve new treatments being trialled in humans for the first time.
After visiting our aseptic production pharmacy to find out how we make patients' cancer treatments on site, the Lord Mayor spent time on our chemotherapy (SACT) treatment unit where she met staff and patients currently having chemotherapy, immunotherapy and similar treatments.
As a recognised poet and artist, the Lord Mayor was also interested in our extensive Arts in Health programme, funded by Clatterbridge Cancer Charity. Evidence shows that arts and culture have a beneficial effect on people's health and wellbeing, including in healthcare settings. Our Arts in Health programme enables patients to take part in and enjoy a vast range of cultural activities including artwork, poetry, musical performances, and creating their own work.
Joan Spencer, Chief Executive of The Clatterbridge Cancer Centre, said: "It was an honour and an absolute pleasure to welcome the Lord Mayor of Liverpool to Clatterbridge Cancer Centre - Liverpool. As the region's specialist cancer hospital, we are hugely ambitious about delivering the most advanced, compassionate and effective care for our patients so that everyone with cancer has the best possible experience and outcome. The Lord Mayor was impressed by the hospital environment and the dedication of our staff."
Liverpool Town Hall
Liverpool City Council
14/04/2026
Data from Clatterbridge patients has been used in research that could change UK clinical practice in prostate cancer care.
This major national study has shown that artificial intelligence can significantly improve predictions about how a patient’s prostate cancer is likely to behave.
The findings come from biopsies taken in the CHHiP clinical trial from hundreds of men treated for localised prostate cancer at CCC between 2002 and 2011, and their health monitored for more than 10 years afterwards.
Earlier this month, The Clatterbridge Cancer Centre hosted doctors in training to prepare them for their upcoming Fellow of the Royal College of Radiologists (FRCR) clinical oncology Part 2B Exams.
The FRCR Part 2B examines candidates on all aspects of clinical oncology. Clinical oncologists use both radiotherapy and medication treatments to treat patients and the exam tests trainees on clinical decision making, radiotherapy planning skills and clear communication. All future clinical oncologists have to obtain this qualification as part of their training.
Staff from across The Clatterbridge Cancer Centre joined in the session to support the participants and give their expert advice on key aspects of clinical oncology relevant to the exam . Staff supporting included some of our Consultant Cclinical oncologists as well as consultant radiographers, senior clinical oncology registrars and medical education staff.
Clinical oncology registrars from across the country took part in the session online, with doctors joining from Newcastle, London, Belfast, Sheffield and as far afield as Malaysia.
The Clatterbridge Cancer Centre is renowned for the excellent standard of training it offers to doctors in training, with the session receiving excellent feedback with participants praising the organisation of the course and its usefulness in preparing them for their upcoming exams.
Dr Jas Latif, Consultant in Clinical Oncology at The Clatterbridge Cancer Centre, led the session. She said: “The turn out from colleagues across the Trust to support doctors in training at this session is testament to the high level of education we offer here. Thank you so much to them for giving up their time to instil their knowledge and help candidates feel more confident in their upcoming exam.”
“The FRCR Part 2B Exam is a high-pressured exam, essential to the training of any clinical oncologist. We want to ensure candidates are as prepared as possible to take on the exam. The more knowledge they have, ultimately, the better care we can all provide to patients of the future.”
06/04/2026
Resident Doctors are due to take industrial action from 7am on Tuesday 7 April to 7am on Monday 13 April 2026.
Please attend your appointment with us as usual unless we contact you to say otherwise.
If you need to access care during this time:
• Our Hotline team is available 24/7 – including strike days – on 0800 169 5555 for anyone who is currently being treated at CCC or who completed treatment in the last six weeks and who needs urgent care or advice (e.g. due to treatment side-effects). Please note the hotline is for unwell patients only and not for appointment queries.
Be the first to know and let us send you an email when The Clatterbridge Cancer Centre posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Clatterbridge Cancer Centre NHS Foundation Trust is one of the UK’s leading cancer centres providing highly specialist cancer care to a population of 2.3m people across Cheshire, Merseyside and the surrounding areas including the Isle of Man.
We are based in Wirral, Merseyside supported by a £17m radiotherapy treatment centre in Aintree, Liverpool. We also operate specialist chemotherapy clinics in seven of Merseyside’s district hospitals and deliver a pioneering Treatment at Home service.
Together, this enables us to provide a comprehensive range of inpatient care, advanced radiotherapy, chemotherapy and other systemic anti-cancer therapies (i.e. medicines) including gene therapies and immunotherapies. We are also the only facility in the UK providing low-energy proton beam therapy to treat rare eye cancers and host the region’s Teenage and Young Adult Unit, (supported by the Teenage Cancer Trust).
We are a tertiary cancer centre which means we see patients who have already been diagnosed and referred to us by other hospitals. We provide non-surgical cancer care e.g. chemotherapy and radiotherapy for solid tumours and blood cancers.
Our services include:
Academic oncology – professors and senior clinical lecturers appointed jointly with the University of Liverpool
Acute oncology – specialist cancer support in A&E and acute care in other hospitals
Chemotherapy and other systemic anti-cancer treatments (SACT). These are drug treatments for cancer and include gene therapies, immunotherapies and other molecular agents
Haemato-oncology – in July 2017 the management of the Royal Liverpool University Hospital’s Haemato-oncology service transferred to The Clatterbridge Cancer Centre. This service provides inpatient and outpatient care for acute leukaemia; chronic leukaemia; lymphoma; myeloma and bone marrow (stem cell) transplant
Eye proton therapy – we have the UK’s only low-energy proton beam therapy facility for treating rare eye tumours
Imaging and pre-treatment radiotherapy (diagnostic imaging / treatment planning) – we have PET-CT, CT, MRI, x-ray facilities and treatment planning
Inpatient wards – we have 73 inpatient beds across our three wards on our Wirral site
Pharmacy – we manufacture all the chemotherapy doses for solid tumour cancers in Cheshire & Merseyside
Physics – our physicists provide essential scientific support for radiotherapy treatment
Radiotherapy – we have 10 linear accelerators (radiotherapy treatment machines). Six at the Wirral site; three at the Aintree site; one in the Clatterbridge Private Clinic
Research & development – we carry out leading-edge clinical trials of new cancer treatments. Our BioBank of donated tissue provides a valuable resource for cancer researchers
Supportive care – including physiotherapy, psychological support, palliative care, speech and language therapy, occupational therapy, dietetics, cancer information, financial / benefits advice, and survivorship / living with and beyond cancer
Triage & assessment – we provide rapid-access assessment clinics and 24-hour phone support for patients who need urgent advice or care while having cancer treatment
We are expanding and improving cancer care even further with the development of a new 11-floor specialist cancer hospital in the heart of Liverpool. The new cancer hospital is due to open in 2020 and will provide highly-specialist cancer care for people with blood cancers and solid tumours. Although the Liverpool hospital will become our main base, we will also continue providing services at our current site in Wirral and our satellite radiotherapy centre on the Aintree site.
Being located in central Liverpool alongside the University of Liverpool and Royal Liverpool University Hospital will significantly improve care for people with cancer:
Our main base will be closer to the majority of the population we serve, which stretches from Southport down to Wirral and across to Widnes / Warrington. People who live closer to Wirral / Aintree will still be able to access care locally as we’re keeping our current sites
Unlike now, we will be co-located with a major acute teaching hospital providing rapid access to intensive care and other key medical and surgical specialties when patients need them. At the moment these patients have to be transferred by emergency ambulance to other hospitals
We will be at the heart of a thriving research and healthcare campus with the University of Liverpool, NHS and other key research partners, enabling even more ground breaking cancer research and clinical trials.
You can find out more about the new building here.
